Glenmark Pharma to launch its nasal spray Ryaltris in EU ...Middle East

Devdiscourse - Opinion
Glenmark Pharma to launch its nasal spray Ryaltris in EU
Glenmark Pharma on Monday said it is concluding the final, national phase of its marketing approval application process to launch its nasal spray Ryaltris in 17 countries in the European Union (EU). Glenmark said Ryaltris is now approved in Europe for the first line treatment of allergic rhinitis in patients over 12 years of age. Ryaltris is indicated for symptomatic treatment of seasonal and perennial allergic rhinitis in adults and children over 12 years of age. The drug relieves symptoms of allergic rhinitis, including stuffy nose, runny nose, nasal itching, sneezing, as well as itchy, red and watery eyes.

Hence then, the article about glenmark pharma to launch its nasal spray ryaltris in eu was published today ( ) and is available on Devdiscourse ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Glenmark Pharma to launch its nasal spray Ryaltris in EU )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in Opinion